Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: J Abnorm Psychol. 2019 Jun 13;128(5):473–486. doi: 10.1037/abn0000438

Table 1.

Unweighted prevalence rates (%) of the criteria for each dataset and subsample. Only the unweighted prevalence rates are included here because the unweighted data are used in the network estimation method.

Sample LL CD TS CR FF SI GU HZ PP TL WD N
NESARC Wave 2
 Full Data 8.8 8.1 1.8 2.7 0.7 1.5 0.6 6.8 3.3 4.4 5.0 34,629
 PY Drink 13.8 12.7 2.8 4.2 1.1 2.4 1.0 10.6 5.1 6.8 7.8 22,160
 PY Binge 41.5 30.8 11.5 14.2 4.5 9.7 4.3 32.9 17.7 16.5 23.3 3,458
 PY Symptomatic 47.7 43.8 9.8 14.4 3.7 8.3 3.4 36.7 17.6 23.6 26.8 6,412
NESARC III
 Full Data 10.6 9.9 3.8 7.8 1.5 4.5 1.4 8.0 5.2 5.7 7.7 34,712
 PY Drink 14.8 13.8 5.3 10.9 2.1 6.4 2.0 11.2 7.3 8.0 10.9 24,773
 PY Binge 40.8 32.5 18.4 29.8 7.4 20.1 7.1 29.4 23.3 21.6 30.7 4,959
 PY Symptomatic 47.0 43.9 16.9 34.6 6.6 20.2 6.3 35.5 23.2 25.4 34.4 7,810

Note: The 11 criteria are larger amounts/longer use (LL), inability to cut down (CD), spend a lot of time obtaining/drinking/recovering from its effects (TS), craving (CR), failure to fulfill major roles and obligations (FF), social/interpersonal problems (SI), give up activities (GU), hazardous use (HZ), use despite physical/psychological problems (PP), tolerance (TL), and withdrawal (WD).